- Home
- Products
- Customized ADCs
- TMEFF2
- Anti-TMEFF2-Mc-MMAF ADC-1
Anti-TMEFF2-Mc-MMAF ADC-1 (CAT#: ADC-W-088)
This ADC product is comprised of an anti-TMEFF2 monoclonal antibody conjugated (TMEFF2#19) via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- TMEFF2
- Alternative Names
- TMEFF2; transmembrane protein with EGF-like and two follistatin-like domains 2; TR; HPP1; TPEF; TMEFF2; CT120.2; tomoregulin-2; TR-2; tomoregulin; transmembrane protein TMEFF2; hyperplastic polyposis protein 1; cancer/testis antigen family 120, member 2;
- Target Entrez Gene ID
- 23671
- Target UniProt ID
- Q9UIK5
- Overview
- TENB2 encodes a putative transmembrane proteoglycan, related to the EGF/heregulin family of growth factors and follistatin, which has been identified through the application of a differential display technique to a xenograft model of prostate cancer.
- Overview
- Humanized Anti-TMEFF2-antibody, TMEFF2#19
- Generic name
- TMEFF2#19
- Species Reactivity
- Human
- Name
- Mc (maleimidocaproyl)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
- Name
- MMAF (Monomethyl auristatin F)
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD3E (Visilizumab)-SMCC-DM1 ADC (CAT#: ADC-W-842)
- Anti-EGFR-Mc-MMAF ADC-1 (CAT#: ADC-W-035)
- Anti-CEACAM1 (Arcitumomab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-966)
- Anti-CD74-Mc-VC-PABC-MMAF ADC-4 (CAT#: ADC-W-377)
- Anti-IgE Fc (Talizumab)-SPDB-DM4 ADC (CAT#: ADC-W-2151)
- Anti-IAV HA (Diridavumab(CR6261))-SMCC-DM1 ADC (CAT#: ADC-W-2066)
- Anti-NGF (Fulranumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1661)
- Anti-IL5 (Reslizumab)-SPDB-DM4 ADC (CAT#: ADC-W-1395)
- Anti-Fibrin II-beta chain (Biciromab)-SPDB-DM4 ADC (CAT#: ADC-W-1995)
- Anti-Pseudomonas aeruginosa serotype IATS O11 (Panobacumab)-SPDB-DM4 ADC (CAT#: ADC-W-2031)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-088. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-441 | Anti-TMEFF2-VC-MMAE ADC-2 | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-437 | Anti-TMEFF2-Mc-VC-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
| ADC-W-089 | Anti-TMEFF2-Mc-VC-PABC-MMAE ADC-1 | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
| ADC-W-086 | Anti-TMEFF2-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-087 | Anti-TMEFF2-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-517 | Anti-TM4SF1-Mc-LP2 ADC-1 | Mc (maleimidocaproyl) | LP2 (chemical name mc-3377) |
| ADC-W-518 | Anti-TM4SF1-Mc-LP2 ADC-2 | Mc (maleimidocaproyl) | LP2 (chemical name mc-3377) |
| ADC-W-485 | Anti-EphA2-Mc-MMAF ADC-1 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-491 | Anti-TNFRSF17-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-537 | Anti-TPBG-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-491 | Anti-TNFRSF17-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-AA-020 | anti-MIgG(Fc)-C-MMAF ADC | Cleavable linkers | MMAF (Monomethyl auristatin F) |
| ADC-AA-053 | Protein A-MMAF ADC | MMAF (Monomethyl auristatin F) | |
| ADC-AA-049 | Protein G-MMAF ADC | MMAF (Monomethyl auristatin F) | |
| ADC-AA-028 | anti-MIgG(Fc)Fab-C-MMAF ADC | Cleavable linkers | MMAF (Monomethyl auristatin F) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
